Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers
- 30 November 2008
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 30 (11) , 2051-2068
- https://doi.org/10.1016/j.clinthera.2008.11.008
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- (883): Impact on quality of life of constipation-associated GI symptoms related to opioid treatment in chronic pain patients: PAC-QOL results from the opioid surveyThe Journal of Pain, 2007
- (882): OBD symptoms impair quality of life and daily activities, regardless of frequency and duration of opioid treatment: Results of a US patient survey (PROBE survey)The Journal of Pain, 2007
- Difficult painBMJ, 2006
- OxycodoneJournal of Pain and Symptom Management, 2005
- Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathyPAIN®, 2003
- Opioid-Induced Bowel DysfunctionDrugs, 2003
- Opioid Antagonists: A Review of Their Role in Palliative Care, Focusing on Use in Opioid-Related ConstipationJournal of Pain and Symptom Management, 2002
- An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancerPalliative Medicine, 1996
- The socioeconomic impact of chronic painDisability and Rehabilitation, 1994
- Decline in abuse of pentazocine/tripelennamine (T's and Blues) associated with the addition of naloxone to pentazocine tabletsDrug and Alcohol Dependence, 1984